3-71198338-G-A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001349338.3(FOXP1):​c.44C>T​(p.Ala15Val) variant causes a missense change. The variant allele was found at a frequency of 0.00023 in 1,585,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

FOXP1
NM_001349338.3 missense

Scores

2
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1B:7

Conservation

PhyloP100: 7.00
Variant links:
Genes affected
FOXP1 (HGNC:3823): (forkhead box P1) This gene belongs to subfamily P of the forkhead box (FOX) transcription factor family. Forkhead box transcription factors play important roles in the regulation of tissue- and cell type-specific gene transcription during both development and adulthood. Forkhead box P1 protein contains both DNA-binding- and protein-protein binding-domains. This gene may act as a tumor suppressor as it is lost in several tumor types and maps to a chromosomal region (3p14.1) reported to contain a tumor suppressor gene(s). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13815469).
BP6
Variant 3-71198338-G-A is Benign according to our data. Variant chr3-71198338-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 211043.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=4, Benign=2}.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000176 (26/147720) while in subpopulation NFE AF = 0.000282 (19/67368). AF 95% confidence interval is 0.000184. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXP1NM_001349338.3 linkc.44C>T p.Ala15Val missense_variant Exon 6 of 21 ENST00000649528.3 NP_001336267.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXP1ENST00000649528.3 linkc.44C>T p.Ala15Val missense_variant Exon 6 of 21 NM_001349338.3 ENSP00000497369.1 Q9H334-1
ENSG00000285708ENST00000647725.1 linkc.44C>T p.Ala15Val missense_variant Exon 11 of 26 ENSP00000497585.1

Frequencies

GnomAD3 genomes
AF:
0.000176
AC:
26
AN:
147720
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000745
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000277
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000282
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000239
AC:
60
AN:
251386
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000422
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000236
AC:
339
AN:
1438218
Hom.:
0
Cov.:
36
AF XY:
0.000239
AC XY:
171
AN XY:
715320
show subpopulations
African (AFR)
AF:
0.0000912
AC:
3
AN:
32890
American (AMR)
AF:
0.000204
AC:
9
AN:
44012
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25294
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37884
South Asian (SAS)
AF:
0.0000930
AC:
8
AN:
86030
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51198
Middle Eastern (MID)
AF:
0.000178
AC:
1
AN:
5616
European-Non Finnish (NFE)
AF:
0.000278
AC:
305
AN:
1096464
Other (OTH)
AF:
0.000221
AC:
13
AN:
58830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000176
AC:
26
AN:
147720
Hom.:
0
Cov.:
31
AF XY:
0.000168
AC XY:
12
AN XY:
71630
show subpopulations
African (AFR)
AF:
0.0000745
AC:
3
AN:
40270
American (AMR)
AF:
0.000277
AC:
4
AN:
14444
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3450
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4844
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4556
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9558
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
300
European-Non Finnish (NFE)
AF:
0.000282
AC:
19
AN:
67368
Other (OTH)
AF:
0.00
AC:
0
AN:
2024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000347
Hom.:
0
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ExAC
AF:
0.000272
AC:
33
EpiCase
AF:
0.000545
EpiControl
AF:
0.000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 28, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31474318) -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FOXP1: PP3, BS1 -

Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1Benign:1
Feb 08, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 17, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital cerebellar hypoplasia Pathogenic:1
-
University of Washington Center for Mendelian Genomics, University of Washington
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Cerebellar vermis hypoplasia;C4013764:Intellectual disability-severe speech delay-mild dysmorphism syndrome Pathogenic:1
Feb 18, 2019
Dobyns Lab, Seattle Children's Research Institute
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

FOXP1-related disorder Benign:1
Jun 29, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Jan 22, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Intellectual disability-severe speech delay-mild dysmorphism syndrome Benign:1
Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.19
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.25
T;.;T;.;T;.;.;.;.;T;.;.;T;.;T;.;.;T;.;.;.;.;.;.;.;.;.;.;.
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
.;D;.;.;.;.;D;.;D;.;D;D;.;D;D;D;D;D;D;D;.;.;.;D;D;.;D;.;.
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Benign
2.0
M;M;M;M;M;.;.;M;.;M;M;.;M;M;M;.;.;.;.;.;M;M;M;M;.;.;.;.;.
PhyloP100
7.0
PROVEAN
Benign
-0.52
N;.;N;N;.;.;.;.;.;N;N;.;.;.;.;N;.;.;.;.;.;N;.;.;.;.;.;.;.
REVEL
Uncertain
0.38
Sift
Benign
0.17
T;.;T;T;.;.;.;.;.;T;T;.;.;.;.;T;.;.;.;.;.;D;.;.;.;.;.;.;.
Sift4G
Benign
0.25
T;T;T;T;.;.;.;.;.;T;T;.;.;.;.;T;.;.;.;.;T;T;.;.;.;.;.;.;.
Polyphen
0.0030
B;.;B;.;B;.;.;.;.;B;.;.;B;.;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.18
MVP
0.54
ClinPred
0.061
T
GERP RS
5.6
PromoterAI
0.095
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.40
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs532329866; hg19: chr3-71247489; COSMIC: COSV100562307; API